用司美格鲁肽减重后停药，44%的人都后悔了！

Core Viewpoint - The article discusses the rising obesity rates in China and the impact of GLP-1 receptor agonists, particularly semaglutide, on weight management and the challenges associated with medication adherence and weight maintenance after discontinuation [2][3]. Group 1: Obesity Statistics in China - China has the highest number of overweight and obese individuals globally, with over 50% of the adult population classified as overweight or obese, totaling approximately 532 million people, including nearly 100 million who are obese [2]. - A 2020 study predicts that by 2030, the number of overweight adults in China will reach 540 million, and the number of obese individuals will increase to 150 million, representing a 2.8-fold and 7.5-fold increase from 2000, respectively [2]. Group 2: Medication Adherence and Discontinuation - Research indicates that semaglutide has the highest adherence rate among weight loss medications, with 63% of patients still using it after three months, 56% after six months, and 40% after one year [5]. - Common reasons for discontinuation include side effects such as nausea, diarrhea, and gastrointestinal issues, which can lead to a significant percentage of patients stopping the medication [9][10]. Group 3: Effects of Discontinuation - A clinical trial showed that participants who stopped semaglutide after a 20-week treatment regained an average of 6.9% of their body weight, while those who continued lost an additional 7.9% [6]. - An observational study found that 18% of patients regained their lost weight after one year of stopping semaglutide, with 26% regaining more than 25% of their lost weight [6]. Group 4: Reasons for Stopping Medication - Patients may stop using semaglutide due to side effects, reaching a weight loss plateau, or achieving their target weight [11][13][14]. - The lack of insurance coverage for semaglutide when used for weight loss also contributes to discontinuation [12]. Group 5: Recommendations for Discontinuation - Gradually reducing the dosage of GLP-1 receptor agonists is recommended to minimize rebound hunger and manage weight effectively after stopping the medication [15][17]. - Maintaining a healthy lifestyle, including diet and exercise, is crucial for preventing weight regain after discontinuation [17]. Group 6: Lifestyle Management - The latest guidelines emphasize that lifestyle interventions, including dietary management, exercise, and behavioral changes, are essential for long-term weight management [18]. - Various dietary patterns, such as low-calorie diets and intermittent fasting, can lead to weight loss, but individual adherence is critical for sustained results [19][21]. - Exercise contributes to long-term weight maintenance and improves overall quality of life, despite only achieving modest weight loss on its own [22]. Group 7: Importance of Continued Medication - Long-term use of semaglutide is necessary for effective weight management, as obesity is a chronic condition requiring ongoing treatment [25]. - Studies show that sustained use of semaglutide leads to significant weight loss and maintenance over extended periods, highlighting the importance of adherence to treatment [25].